More importantly, we discovered an additional mode of action of erdafitinib on modulating the transport function of ABCB1 and resensitizing ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic drugs. This evidence concerns the gene ABCB1 and cancer.